Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Study of Topiramate and Olanzapine in the Prevention of Weight Gain in Children and Adolescents With Bipolar Disorder
This study has been completed.
Study NCT00394095   Information provided by University of Cincinnati
First Received: October 27, 2006   Last Updated: October 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
Weight Gain
Additional conditions recognized in this trial
Body Weight
Disease
More general conditions related to this trial
Affective Disorders, Psychotic
Body Weight Changes
Mental Disorders
Mood Disorders
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
olanzapine/topiramate
olanzapine/placebo
Additional drug interventions recognized in this trial
Olanzapine
Topiramate
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Antiemetics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of Cincinnati


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services